InMed Pharmaceuticals Inc. Common Shares (INM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for InMed Pharmaceuticals Inc. Common Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.60
+1.80% today
Market cap
$9M
Overall quality
—
Kronos AI 30-day
−4.9%
3 of 8 simulated paths end higher
InMed Pharmaceuticals Inc. Common Shares (INM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $9M. It trades at $1.60, up 1.80% today. Kronos AI's 30-day forecast is −4.9% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.51 (−4.9%) |
| Likely range | −13.9% … +1.9% |
| As of | 2026-10-27 |
3 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.